Acute tubular necrosis after renal transplantation

Transplantation
D BrophyC M Kjellstrand

Abstract

We evaluated the influence of dialysis requiring acute tubular necrosis on patient survival, and kidney survival and function in all 182 patients who needed dialysis immediately after transplantation at the University of Minnesota Hospitals. When compared to matched control patients not requiring dialysis, there was no difference at any point in patient survival. At 1 month there were more kidneys lost in the patients who developed acute tubular necrosis, but this difference was not present at 3 months or later. Acute tubular necrosis is a relatively innocent complication of renal transplantation and, if one avoids assaulting patients with invasive diagnostic procedures, does not give rise to an increased mortality nor, in the long run, to an increased loss of kidneys. Therefore, kidneys should not be discarded because of fear they might develop this complication.

Citations

May 1, 1993·Transplant International : Official Journal of the European Society for Organ Transplantation·H H DöşlüoğluS Ercan
Jan 1, 1990·Biology of Metals·C G ElinderB Palm
Jan 1, 1986·International Urology and Nephrology·A NotghiG D Chisholm
Dec 29, 1995·European Journal of Pharmacology·R ParoniR Trazzi
Dec 1, 1987·The Journal of Surgical Research·A J MatasF J Veith
Dec 1, 1999·Transplantation Proceedings·F López-NeblinaA L Arteaga Barcaz
May 8, 1986·The New England Journal of Medicine·UNKNOWN Canadian Multicentre Transplant Study Group
Dec 18, 2002·International Journal of Experimental Pathology·Telma J SoaresTerezila M Coimbra
Apr 23, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R VanholderN Lameire
Jun 14, 2005·Transplant International : Official Journal of the European Society for Organ Transplantation·Iris FontanaUmberto Valente
Jan 1, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·O GünalR Yalin
Jun 1, 1989·The Journal of Surgical Research·R M PodrazikL G D'Alecy
Aug 1, 1989·Transplant International : Official Journal of the European Society for Organ Transplantation·P SmitsR Koene
Jan 1, 1981·Clinical and Experimental Dialysis and Apheresis·C M KjellstrandT Davin
Jan 1, 1983·Clinical and Experimental Dialysis and Apheresis·K V Rao, C M Kjellstrand
Jan 1, 1991·Scandinavian Journal of Urology and Nephrology·L FrostH E Hansen
May 24, 2011·International Journal of Surgery·F HanifE Murio
Sep 17, 1999·São Paulo Medical Journal = Revista Paulista De Medicina·M MazzaliG Alves Filho
Aug 1, 1985·The Australian and New Zealand Journal of Surgery·D R EisingerA G Sheil
May 13, 2003·Renal Failure·Hitchintan KaurKanwaljit Chopra
Oct 11, 2001·American Journal of Physiology. Renal Physiology·D P BasileJ L Osborn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.